Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PLX | AZN | AMGN | GILD | BMY |
| Company | Protalix Biotherapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.42 | 170.70 | 383.25 | 133.11 | 63.65 |
| High | 2.42 | 174.44 | 398.00 | 136.26 | 64.97 |
| Low | 2.34 | 170.67 | 382.21 | 132.63 | 63.20 |
| Latest | 2.34 | 172.90 | 393.57 | 134.75 | 64.48 |
| Change | -0.06 | +3.26 | +17.31 | +4.23 | +1.92 |
| % Change | -2.50% | +1.92% | +4.60% | +3.24% | +3.07% |
| Volume | 48,492 | 1,197,233 | 1,110,090 | 2,007,972 | 2,642,127 |
| 20-Day Average Volume | 498,486 | 2,738,002 | 2,159,556 | 6,360,840 | 9,806,390 |
| Previous Close | 2.40 | 169.64 | 376.26 | 130.52 | 62.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.36 | 175.82 | 367.72 | 131.64 | 59.44 |
| 20-Day Raw Stochastic | 54.35% | 29.89% | 99.97% | 62.58% | 99.25% |
| 20-Day Relative Strength | 56.94 | 46.81 | 69.51 | 54.98 | 65.90 |
| Weighted Alpha | +53.28 | +8.20 | +36.26 | +15.68 | +46.23 |
| Today's Opinion | 56% Buy | 88% Sell | 100% Buy | 24% Buy | 72% Buy |
| Previous Opinion | 56% Buy | 88% Sell | 100% Buy | 40% Sell | 72% Buy |
| Last Month's Opinion | Hold | 16% Sell | 56% Buy | 56% Sell | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.64% since 07/21/26 | +2.59% since 07/21/26 | +7.90% since 07/21/26 | +3.21% since 07/21/26 | +6.06% since 07/21/26 |
| Low | 2.31 on 07/22/26 | 166.04 on 07/23/26 | 359.21 on 07/23/26 | 127.61 on 07/23/26 | 60.45 on 07/23/26 |
| High | 2.46 on 07/27/26 | 174.39 on 07/28/26 | 395.20 on 07/28/26 | 135.01 on 07/28/26 | 64.68 on 07/28/26 |
| 1-Month | |||||
| %Chg | +3.26% since 06/26/26 | -7.79% since 06/26/26 | +10.29% since 06/26/26 | +5.15% since 06/26/26 | +12.35% since 06/26/26 |
| Low | 2.25 on 07/17/26 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 124.19 on 06/30/26 | 56.30 on 07/01/26 |
| High | 2.48 on 07/13/26 | 196.41 on 07/02/26 | 395.20 on 07/28/26 | 140.61 on 07/17/26 | 64.68 on 07/28/26 |
| 3-Month | |||||
| %Chg | +12.03% since 04/28/26 | -6.94% since 04/28/26 | +16.38% since 04/28/26 | +4.03% since 04/28/26 | +10.92% since 04/28/26 |
| Low | 1.88 on 05/19/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 2.48 on 07/13/26 | 196.41 on 07/02/26 | 395.20 on 07/28/26 | 140.61 on 07/17/26 | 64.68 on 07/28/26 |
| 6-Month | |||||
| %Chg | +15.29% since 01/28/26 | -6.82% since 01/28/26 | +15.48% since 01/28/26 | -3.76% since 01/28/26 | +18.31% since 01/28/26 |
| Low | 1.88 on 05/19/26 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 3.19 on 02/23/26 | 212.71 on 02/18/26 | 395.20 on 07/28/26 | 157.29 on 02/11/26 | 64.68 on 07/28/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 193,373 | 263,096,016 | 203,070,544 | 162,049,712 | 127,751,968 |
| Shares Outstanding, K | 80,572 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 52,740,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -6,600,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 33,750,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 18,320,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.00 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 05/13/26 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/13/26 | 07/27/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 13.17 | 18.28 | 17.02 | 15.45 | 10.47 |